Publications by authors named "S Pisconti"

Claim this Profile
L
Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients.
L Arenare, C Porta, D Barberio, S Terzolo, V Zagonel, S Pisconti

J Cancer Policy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial.
D Ciardiello, G Martini, L Boscolo Bielo, F Pietrantonio, A Raimondi, S Pisconti

Ann Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy.
L Boscolo Bielo, S Napolitano, A Avallone, F Pietrantonio, R Bordonaro, S Pisconti

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating tissue and liquid biopsy comprehensive genomic profiling to predict efficacy of anti-EGFR therapies in metastatic colorectal cancer: Findings from the CAPRI-2 GOIM study.
Davide Ciardiello, Luca Boscolo Bielo, Stefania Napolitano, Eleonora Cioli, Tiziana Pia Latiano, Salvatore Pisconti

Eur J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apalutamide Monotherapy in Metastatic Hormone-Sensitive Prostate Cancer: A Viable Alternative to First-Generation Anti-Androgen Agents to Avoid the Flare Phenomenon and an Effective Treatment for Achieving Early PSA Response.
Gaetano Facchini, Andrea D'Arienzo, Antonella Nicastro, Fabiano Flauto, Michela Izzo, Salvatore Pisconti

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis